---
title: "CETC: CETC Investment increased its stake in the company by 0.41%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232081335.md"
description: "CETC announced that the acquirer, China Electronics Technology Investment Holding Co., Ltd., will increase its holdings of the company's A-shares by 4.7953 million shares through the centralized bidding method of the Shanghai Stock Exchange from December 20, 2024, to March 13, 2025, with an increase ratio of 0.41%. Before this acquisition, CETC Investment held 12.29% of the company's shares, and after the acquisition, the holding ratio will be 12.70%"
datetime: "2025-03-17T11:42:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232081335.md)
  - [en](https://longbridge.com/en/news/232081335.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232081335.md)
generator: "portal-rs"
---

# CETC: CETC Investment increased its stake in the company by 0.41%

CETC announced that the acquirer, China Electronics Technology Investment Holding Co., Ltd., will increase its holdings of the company's A-shares by 4.7953 million shares through the centralized bidding method of the Shanghai Stock Exchange from December 20, 2024, to March 13, 2025, with an increase ratio of 0.41%. Before this acquisition, CETC Investment held 12.29% of the company's shares, and after the acquisition, the holding ratio will be 12.70%

### Related Stocks

- [600877.CN](https://longbridge.com/en/quote/600877.CN.md)

## Related News & Research

- [The Platform Group: Acquired Cocoli.com to strengthen the furniture marketplace, with EUR 728M revenue in 2025](https://longbridge.com/en/news/296441852.md)
- [Tiger Global Added to Its Position in Intel in Q2](https://longbridge.com/en/news/296504813.md)
- [07:12 ETPROYA s'associe à Ulta Beauty : élargir l'éventail des soins haut de gamme de ce détaillant dans le courant de l'année](https://longbridge.com/en/news/296480642.md)
- [DIMRI: H1 2026 net profit rose to ₪495.6M on revenue of ₪780.5M, with robust liquidity and equity](https://longbridge.com/en/news/296448412.md)
- [Tvardi Therapeutics: TTI-109, an oral STAT3 inhibitor, targets unmet needs in UC with promising safety and efficacy data](https://longbridge.com/en/news/296388332.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**